Product Information
PROMETHAZINE-CODEINE SOLUTION is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $0.0697 per ML under NDC 70752013912. Its NADAC has been published 289 times since Mar 24, 2021.
FDA first approved this application on Oct 8, 2020. Its Orange Book therapeutic-equivalence code is AA.
Strength
10; 6.25 mg/5mL; mg/5mL
Manufacturer
Quagen Pharmaceuticals LLCNDC
70752013912
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214238FDA Approved
10/8/2020
TE Code
AA
On Market Since
10/8/2020
Pharmacological Classes
Price Statistics
The NADAC for PROMETHAZINE-CODEINE SOLUTION has been published 289 times since Mar 24, 2021, and over the history we have for it it has risen 30.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0697 per ML |
|---|---|
| All-time high | $0.0697 (Sep 30, 2026) |
| All-time low | $0.0301 (Feb 22, 2023) |
| 52-week high | $0.0697 |
| 52-week low | $0.0406 |
| Median price | $0.0412 |
| Average price | $0.0441 |
| Largest weekly change | +28.2% (May 19, 2021) |
| Weeks tracked | 289 |
| Tracking since | Mar 24, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quagen Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Promethazine Hydrochloride and Codeine Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROMETHAZINE-CODEINE SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for PROMETHAZINE-CODEINE SOLUTION, manufactured by Quagen Pharmaceuticals LLC, is $0.0697 per ML (NDC 70752013912), effective Sep 30, 2026.
How has the price of PROMETHAZINE-CODEINE SOLUTION changed over time?
Over the history we have for it, the NADAC for PROMETHAZINE-CODEINE SOLUTION has risen 30.2%. It has been tracked across 289 weekly CMS publications since Mar 24, 2021.
What are the highest and lowest recorded NADAC prices for PROMETHAZINE-CODEINE SOLUTION?
Since Mar 24, 2021, the NADAC for PROMETHAZINE-CODEINE SOLUTION has ranged from a low of $0.0301 (Feb 22, 2023) to a high of $0.0697 (Sep 30, 2026), with a median of $0.0412 per ML.
Are there cheaper alternatives to PROMETHAZINE-CODEINE SOLUTION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PROMETHAZINE-CODEINE SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures PROMETHAZINE-CODEINE SOLUTION?
PROMETHAZINE-CODEINE SOLUTION (NDC 70752013912) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.